Skip to content
Brand AI

Hangzhou Tigermed Consulting Co., Ltd.

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2026

    Actual Controllers Penalized for Disclosing Equity Changes Nearly 7 Years Late

    Actual controllers Ye Xiaoping and Cao Xiaochun failed to timely disclose cumulative shareholding changes reaching 5% in 2019 and a 1% reduction in 2022, and only supplemented disclosure in 2026; in 2015, a subsidiary was also cited as non-compliant in a clinical data self-inspection. The two are planned to be fined RMB 500,000 each.

    Source